Literature DB >> 21300066

Cellular changes in diabetic and idiopathic gastroparesis.

Madhusudan Grover1, Gianrico Farrugia, Matthew S Lurken, Cheryl E Bernard, Maria Simonetta Faussone-Pellegrini, Thomas C Smyrk, Henry P Parkman, Thomas L Abell, William J Snape, William L Hasler, Aynur Ünalp-Arida, Linda Nguyen, Kenneth L Koch, Jorges Calles, Linda Lee, James Tonascia, Frank A Hamilton, Pankaj J Pasricha.   

Abstract

BACKGROUND & AIMS: Cellular changes associated with diabetic and idiopathic gastroparesis are not well described. The aim of this study was to describe histologic abnormalities in gastroparesis and compare findings in idiopathic versus diabetic gastroparesis.
METHODS: Full-thickness gastric body biopsy specimens were obtained from 40 patients with gastroparesis (20 diabetic) and matched controls. Sections were stained for H&E and trichrome and immunolabeled with antibodies against protein gene product (PGP) 9.5, neuronal nitric oxide synthase (nNOS), vasoactive intestinal peptide, substance P, and tyrosine hydroxylase to quantify nerves, S100β for glia, Kit for interstitial cells of Cajal (ICC), CD45 and CD68 for immune cells, and smoothelin for smooth muscle cells. Tissue was also examined by transmission electron microscopy.
RESULTS: Histologic abnormalities were found in 83% of patients. The most common defects were loss of ICC with remaining ICC showing injury, an abnormal immune infiltrate containing macrophages, and decreased nerve fibers. On light microscopy, no significant differences were found between diabetic and idiopathic gastroparesis with the exception of nNOS expression, which was decreased in more patients with idiopathic gastroparesis (40%) compared with diabetic patients (20%) by visual grading. On electron microscopy, a markedly increased connective tissue stroma was present in both disorders.
CONCLUSIONS: This study suggests that on full-thickness biopsy specimens, cellular abnormalities are found in the majority of patients with gastroparesis. The most common findings were loss of Kit expression, suggesting loss of ICC, and an increase in CD45 and CD68 immunoreactivity. These findings suggest that examination of tissue can lead to valuable insights into the pathophysiology of these disorders and offer hope that new therapeutic targets can be found.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21300066      PMCID: PMC3081914          DOI: 10.1053/j.gastro.2011.01.046

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  50 in total

1.  CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice.

Authors:  Kyoung Moo Choi; Purna C Kashyap; Nirjhar Dutta; Gary J Stoltz; Tamas Ordog; Terez Shea Donohue; Anthony J Bauer; David R Linden; Joseph H Szurszewski; Simon J Gibbons; Gianrico Farrugia
Journal:  Gastroenterology       Date:  2010-02-20       Impact factor: 22.682

2.  Myenteric plexus of obese diabetic mice (an animal model of human type 2 diabetes).

Authors:  A Spångéus; M El-Salhy
Journal:  Histol Histopathol       Date:  2001-01       Impact factor: 2.303

3.  Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes.

Authors:  C L He; E E Soffer; C D Ferris; R M Walsh; J H Szurszewski; G Farrugia
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

4.  Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis.

Authors:  T Ordög; I Takayama; W K Cheung; S M Ward; K M Sanders
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

5.  Electron microscopic observation of gastric mucosal capillaries in diabetics--relationship between diabetic microangiopathy and complications following gastrectomy.

Authors:  S Kihara; K Mori; M Akagi
Journal:  Gastroenterol Jpn       Date:  1983-06

6.  Abnormal intestinal motility in diabetics with the gastroparesis syndrome.

Authors:  M Camilleri; J R Malagelada
Journal:  Eur J Clin Invest       Date:  1984-12       Impact factor: 4.686

7.  Diabetic gastroparesis from autonomic neuropathy: surgical considerations and changes in vagus nerve morphology.

Authors:  R J Guy; J L Dawson; J R Garrett; J W Laws; P K Thomas; A K Sharma; P J Watkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

8.  Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management.

Authors:  N Zárate; F Mearin; X-Y Wang; B Hewlett; J D Huizinga; J-R Malagelada
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

9.  The muscle coat of the lower esophageal sphincter in patients with achalasia and hypertensive sphincter. An electron microscopic study.

Authors:  M S Faussone-Pellegrini; C Cortesini
Journal:  J Submicrosc Cytol       Date:  1985-10

10.  Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.

Authors:  C C Watkins; A Sawa; S Jaffrey; S Blackshaw; R K Barrow; S H Snyder; C D Ferris
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

View more
  164 in total

1.  Fatigue: a prevalent symptom in gastroparesis.

Authors:  Dinu Cherian; Susmita Paladugu; Murali Pathikonda; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2012-06-05       Impact factor: 3.199

2.  Abnormal initiation and conduction of slow-wave activity in gastroparesis, defined by high-resolution electrical mapping.

Authors:  Gregory O'Grady; Timothy R Angeli; Peng Du; Chris Lahr; Wim J E P Lammers; John A Windsor; Thomas L Abell; Gianrico Farrugia; Andrew J Pullan; Leo K Cheng
Journal:  Gastroenterology       Date:  2012-05-27       Impact factor: 22.682

3.  Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis.

Authors:  Pankaj J Pasricha; Katherine P Yates; Linda Nguyen; John Clarke; Thomas L Abell; Gianrico Farrugia; William L Hasler; Kenneth L Koch; William J Snape; Richard W McCallum; Irene Sarosiek; James Tonascia; Laura A Miriel; Linda Lee; Frank Hamilton; Henry P Parkman
Journal:  Gastroenterology       Date:  2015-08-21       Impact factor: 22.682

Review 4.  Gastroparesis: what is the current state-of-the-art for evaluation and medical management? What are the results?

Authors:  Allen Lee
Journal:  J Gastrointest Surg       Date:  2013-06-26       Impact factor: 3.452

5.  Pathophysiology of Gastroparesis Syndromes Includes Anatomic and Physiologic Abnormalities.

Authors:  Thomas L Abell; Archana Kedar; Abigail Stocker; Karen Beatty; Lindsay McElmurray; Michael Hughes; Hani Rashed; William Kennedy; Gwen Wendelschafer-Crabb; Xiu Yang; Mostafa Fraig; Leila Gobejishvili; Endashaw Omer; Ed Miller; Michael Griswold; Christina Pinkston
Journal:  Dig Dis Sci       Date:  2020-04-23       Impact factor: 3.199

Review 6.  Botulinum Toxin Injection for Treatment of Gastroparesis.

Authors:  Trisha S Pasricha; Pankaj J Pasricha
Journal:  Gastrointest Endosc Clin N Am       Date:  2018-09-28

Review 7.  Gastric arrhythmias in gastroparesis: low- and high-resolution mapping of gastric electrical activity.

Authors:  Gregory O'Grady; Thomas L Abell
Journal:  Gastroenterol Clin North Am       Date:  2014-12-29       Impact factor: 3.806

8.  Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: Relationship with etiology, gastric emptying, and symptom severity.

Authors:  Linda Nguyen; Laura A Wilson; Laura Miriel; Pankaj J Pasricha; Braden Kuo; William L Hasler; Richard W McCallum; Irene Sarosiek; Kenneth L Koch; William J Snape; Gianrico Farrugia; Madhusudan Grover; John Clarke; Henry P Parkman; James Tonascia; Frank Hamilton; Thomas L Abell
Journal:  Neurogastroenterol Motil       Date:  2020-02-15       Impact factor: 3.598

9.  Hyperglycemia Increases Interstitial Cells of Cajal via MAPK1 and MAPK3 Signaling to ETV1 and KIT, Leading to Rapid Gastric Emptying.

Authors:  Yujiro Hayashi; Yoshitaka Toyomasu; Siva Arumugam Saravanaperumal; Michael R Bardsley; John A Smestad; Andrea Lorincz; Seth T Eisenman; Gianluca Cipriani; Molly H Nelson Holte; Fatimah J Al Khazal; Sabriya A Syed; Gabriella B Gajdos; Kyoung Moo Choi; Gary J Stoltz; Katie E Miller; Michael L Kendrick; Brian P Rubin; Simon J Gibbons; Adil E Bharucha; David R Linden; Louis James Maher; Gianrico Farrugia; Tamas Ordog
Journal:  Gastroenterology       Date:  2017-04-21       Impact factor: 22.682

10.  Body weight in patients with idiopathic gastroparesis.

Authors:  Henry P Parkman; Mark Van Natta; Goro Yamada; Madhusudan Grover; Richard W McCallum; Irene Sarosiek; Gianrico Farrugia; Kenneth L Koch; Thomas L Abell; Braden Kuo; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha
Journal:  Neurogastroenterol Motil       Date:  2020-09-15       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.